Kodiak LLC
Kodiak Sciences, based in Medford, Oregon, is a biopharmaceutical company dedicated to developing innovative therapies for retinal diseases, focusing on conditions such as age-related macular degeneration, diabetic retinopathy, and retinal vein occlusion. With a robust pipeline that includes advanced investigational treatments like KSI-101 and Tarcocimab Tedromer, Kodiak aims to enhance the quality of life for millions affected by vision impairments.
The company emphasizes a commitment to scientific rigor and innovation, as demonstrated by its ABCD platform and recent clinical trial successes. Kodiak is dedicated to improving patient outcomes through research and development, positioning itself as a leader in the ophthalmology medication space.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.

